Gossamer Bio Inc’s recent filing unveils that its Director Milligan Sandra acquired Company’s shares for reported $50016.0 on Aug 19 ’25. In the deal valued at $1.92 per share,26,050 shares were bought. As a result of this transaction, Milligan Sandra now holds 58,050 shares worth roughly $0.15 million.
UBS upgraded its Gossamer Bio Inc [GOSS] rating to a Buy from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including Scotiabank’s analysts, who began to cover the stock in mid July with a ‘”a Sector outperform”‘ rating. Oppenheimer began covering GOSS with “an Outperform” recommendation on June 25, 2024.
Price Performance Review of GOSS
On Tuesday, Gossamer Bio Inc [NASDAQ:GOSS] saw its stock fall -6.57% to $2.56. Over the last five days, the stock has lost -20.25%. Gossamer Bio Inc shares have risen nearly 163.92% since the year began. Nevertheless, the stocks have fallen -17.42% over the past one year. While a 52-week high of $3.87 was reached on 01/02/26, a 52-week low of $0.76 was recorded on 01/06/26.
Levels Of Support And Resistance For GOSS Stock
The 24-hour chart illustrates a support level at 2.47, which if violated will result in even more drops to 2.37. On the upside, there is a resistance level at 2.71. A further resistance level may holdings at 2.85.
How much short interest is there in Gossamer Bio Inc?
A steep rise in short interest was recorded in Gossamer Bio Inc stocks on 2025-12-15, dropping by -4.11 million shares to a total of 20.31 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-14 was 24.42 million shares. There was a decline of -20.24%, which implies that there is a negative sentiment for the stock.
